Takatsuki, Japan

Yasunori Hase

This inventor holds 1 USPTO granted patent and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Japan Tobacco Inc.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yasunori Hase. Retrieved from https://idiyas.com/inventor/yasunori-hase

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0


 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Yasunori Hase: A Pioneer in Pharmaceutical Compounds

Introduction: Yasunori Hase, a notable inventor located in Takatsuki, Japan, has made significant contributions to the field of pharmaceuticals. With a unique focus on nitrogen-containing spirocyclic compounds, his work has great implications for various medical applications, particularly in the treatment of organ transplant rejection and autoimmune diseases.

Latest Patents: Hase holds a patent for nitrogen-containing spirocyclic compounds along with their pharmaceutical uses. His patent describes a compound of a specific general formula, which may also include pharmaceutically acceptable salts or solvates. The patent highlights the compound's potential in treating conditions such as graft versus host reaction after transplantation, autoimmune diseases, allergic diseases, and chronic myeloproliferative diseases.

Career Highlights: Hase is a prominent figure at Japan Tobacco Inc., where he has been able to leverage his innovative spirit to navigate the complexities of pharmaceutical development. His solitary patent exemplifies his commitment to advancing medical treatments and showcases his ingenuity in a field that directly impacts patient health and well-being.

Collaborations: Throughout his career, Hase has collaborated with esteemed colleagues such as Satoru Noji and Makoto Shiozaki. Their teamwork exemplifies the interconnected nature of scientific research, where sharing ideas and expertise can lead to groundbreaking innovations.

Conclusion: Yasunori Hase's contributions through his patent for nitrogen-containing spirocyclic compounds underscore the importance of inventors in the pharmaceutical industry. His work at Japan Tobacco Inc., along with the collaborative efforts of his peers, reflects a dedication to addressing some of the most pressing health challenges faced today. The innovations he has introduced pave the way for enhanced treatment options and highlight the vital role that inventors play in the advancement of medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…